<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655249</url>
  </required_header>
  <id_info>
    <org_study_id>StLuc AD-VI</org_study_id>
    <nct_id>NCT03655249</nct_id>
  </id_info>
  <brief_title>Effects of AD on VI in Patients With CF</brief_title>
  <official_title>Effects of Autogenic Drainage on Ventilation Inhomogeneity in Patients With Cystic Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effects of a chest physiotherapy manual technique (autogenic
      drainage) on ventilation inhomogeneity in patients with cystic fibrosis. Lung clearance index
      (LCI) is the primary outcome
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-over intervention assessing the effect of autogenic drainage on ventilation
      inhomogeneity in patients with cystic fibrosis.

      Electrical impedance tomography and multiple breath nitrogen washout will be performed
      before, immediatly after and 2h post intervention. Each participant will receive either
      aerosoltherapy alone or in combination with chest physiotherapy on 2 consecutive days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants receive one of two interventions during the first day, and receive the alternative intervention the following day.
Interventions are : aerosoltherapy + autogenic drainage or aerosoltherapy alone</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Lung Clearance Index</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>LCI will be measured before, immediately after and 2h after the experimental or control conditions as well as before and after an hospitalization.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impedance variation</measure>
    <time_frame>Up to 1 hour</time_frame>
    <description>Impedance change in different lung zones</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Cystic Fibrosis</condition>
  <arm_group>
    <arm_group_label>Asl + CPT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerosotherapy + Autogenic drainage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aerosoltherapy alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Autogenic drainage</intervention_name>
    <description>Autogenic drainage is an airway clearance technique that attempts to obtain the optimal airflow to evacuate the secretions. This technique uses modulation of inspiratory and expiratory airflow at different breathing level within the vital capacity.</description>
    <arm_group_label>Asl + CPT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Aerosoltherapy</intervention_name>
    <description>Aerosolized drugs are individualized for each participants, in line with current standardized practice in our hospital. Those drugs will not be modified for the purpose of this study.</description>
    <arm_group_label>Asl</arm_group_label>
    <arm_group_label>Asl + CPT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cystic fibrosis diagnosis

          -  FEV1 &gt; 40%

          -  Able to sustain 30min of chest physiotherapy

        Exclusion Criteria:

          -  Presence of Burkoldheria cepacia or non tuberculous mycobacteria

          -  Orthopedic, neuromuscular or cardiac disorder likely to impact respiratory system

          -  Need for supplemental oxygen

          -  Cardiac pacemaker or internal cardiac defibrillator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory Reychler, PT, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>William Poncin, PT, PhD</last_name>
    <phone>+3227642316</phone>
    <email>william.poncin@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Reychler, PT, PhD</last_name>
    <phone>+3227642316</phone>
    <email>gregory.reychler@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Poncin</last_name>
      <email>william.poncin@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>September 16, 2019</last_update_submitted>
  <last_update_submitted_qc>September 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Multiple breath washout</keyword>
  <keyword>Electrical impedance tomography</keyword>
  <keyword>Lung clearance index</keyword>
  <keyword>Chest physiotherapy</keyword>
  <keyword>Autogenic drainage</keyword>
  <keyword>Cystic fibrosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystic Fibrosis</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

